COVID-19: the new challenge for rheumatologists
Clin Exp Rheumatol
.
2020 Mar-Apr;38(2):175-180.
doi: 10.55563/clinexprheumatol/r3k9l6.
Epub 2020 Mar 24.
Authors
Francesco Ferro
1
,
Elena Elefante
1
,
Chiara Baldini
1
,
Elena Bartoloni
2
,
Ilaria Puxeddu
3
,
Rosaria Talarico
1
,
Marta Mosca
1
,
Stefano Bombardieri
4
Affiliations
1
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
2
Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
3
Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
4
University of Pisa, Italy. s.bombardieri@int.med.unipi.it.
PMID:
32207680
DOI:
10.55563/clinexprheumatol/r3k9l6
No abstract available
Publication types
Editorial
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections
Cytokines
Humans
Pandemics
Pneumonia, Viral
Rheumatologists*
SARS-CoV-2
Substances
Cytokines